Announcements

As all of the articles published in our journal are open access, meaning you have free and unlimited access to the full text. We welcome you to read our most highly cited papers published in 2024, which are listed below:

1. “Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms”
by Othman Al Musaimi
Biomolecules 2024, 14(3), 264; https://doi.org/10.3390/biom14030264
Full text available online: https://www.mdpi.com/2218-273X/14/3/264

2. “Third-Generation Tetracyclines: Current Knowledge and Therapeutic Potential”
by Dimitris Kounatidis, Maria Dalamaga, Eugenia Grivakou, Irene Karampela, Petros Koufopoulos, Vasileios Dalopoulos, Nikolaos Adamidis, Eleni Mylona, Aikaterini Kaziani and Natalia G. Vallianou
Biomolecules 2024, 14(7), 783; https://doi.org/10.3390/biom14070783
Full text available online: https://www.mdpi.com/2218-273X/14/7/783

3. “Curcumin and Resveratrol: Nutraceuticals with so Much Potential for Pseudoachondroplasia and Other ER-Stress Conditions”
by Karen L. Posey
Biomolecules 2024, 14(2), 154; https://doi.org/10.3390/biom14020154
Full text available online: https://www.mdpi.com/2218-273X/14/2/154

4. “Comprehensive Review of Olea europaea: A Holistic Exploration into Its Botanical Marvels, Phytochemical Riches, Therapeutic Potentials, and Safety Profile”
by Hamza Elhrech, Oumayma Aguerd, Chaimae El Kourchi, Monica Gallo, Daniele Naviglio, Imane Chamkhi and Abdelhakim Bouyahya
Biomolecules 2024, 14(6), 722; https://doi.org/10.3390/biom14060722
Full text available online: https://www.mdpi.com/2218-273X/14/6/722

5. “Research Progress on Sesquiterpenoids of Curcumae Rhizoma and Their Pharmacological Effects”
by Ting Cui, Bo-Yu Li, Fei Liu and Liang Xiong
Biomolecules 2024, 14(4), 387; https://doi.org/10.3390/biom14040387
Full text available online: https://www.mdpi.com/2218-273X/14/4/387

6. “Bacteriocins in Cancer Treatment: Mechanisms and Clinical Potentials”
by Yiwen Wang, Yue Wang, Tao Sun and Junnan Xu
Biomolecules 2024, 14(7), 831; https://doi.org/10.3390/biom14070831
Full text available online: https://www.mdpi.com/2218-273X/14/7/831

7. “Assessment of Antimicrobial and Cytotoxic Activities of Liposomes Loaded with Curcumin and Lippia origanoides Essential Oil”
by Juan Pablo Bedoya-Agudelo, Jhon Esteban López-Carvajal, Edwin Stiven Quiguanás-Guarín, Nestor Cardona, Leonardo Padilla-Sanabria and Jhon Carlos Castaño-Osorio
Biomolecules 2024, 14(7), 851; https://doi.org/10.3390/biom14070851
Full text available online: https://www.mdpi.com/2218-273X/14/7/851

8. “Gypenoside XVII Reduces Synaptic Glutamate Release and Protects against Excitotoxic Injury in Rats”
by Cheng-Wei Lu, Tzu-Yu Lin, Kuan-Ming Chiu, Ming-Yi Lee and Su-Jane Wang
Biomolecules 2024, 14(5), 589; https://doi.org/10.3390/biom14050589
Full text available online: https://www.mdpi.com/2218-273X/14/5/589

9. “Effects of Ginger (Zingiber officinale) on the Hallmarks of Aging”
by Maima Matin, Tanuj Joshi, Dongdong Wang, Nikolay T. Tzvetkov, Farhan Bin Matin, Agnieszka Wierzbicka, Artur Jóźwik, Jarosław Olav Horbańczuk and Atanas G. Atanasov
Biomolecules 2024, 14(8), 940; https://doi.org/10.3390/biom14080940
Full text available online: https://www.mdpi.com/2218-273X/14/8/940

10. “Postbiotics of Naturally Fermented Synbiotic Mixture of Rice Water Aids in Promoting Colonocyte Health”
by Charumathi Anbalagan, Sangeetha Kadapakkam Nandabalan, Pavithra Sankar, Prasanna Srinivasan Rajaram, Karthick Govindaraj, Secunda Rupert and Jeswanth Sathyanesan
Biomolecules 2024, 14(3), 344; https://doi.org/10.3390/biom14030344
Full text available online: https://www.mdpi.com/2218-273X/14/3/344

As all of the articles published in our journal are open access, meaning you have free and unlimited access to the full text. We welcome you to read our most highly cited papers published in 2024, which are listed below:

1. “The Role of MUC1 in Renal Cell Carcinoma”
by Martina Milella, Monica Rutigliano, Francesco Lasorsa, Matteo Ferro, Roberto Bianchi, Giuseppe Fallara, Felice Crocetto, Savio Domenico Pandolfo, Biagio Barone, Antonio d’Amati et al.
Biomolecules 2024, 14(3), 315; https://doi.org/10.3390/biom14030315
Full text available online: https://www.mdpi.com/2218-273X/14/3/315

2. “The Role of the Brain-Derived Neurotrophic Factor in Chronic Pain: Links to Central Sensitization and Neuroinflammation”
by Huan-Yu Xiong, Jolien Hendrix, Siobhan Schabrun, Arne Wyns, Jente Van Campenhout, Jo Nijs and Andrea Polli
Biomolecules 2024, 14(1), 71; https://doi.org/10.3390/biom14010071
Full text available online: https://www.mdpi.com/2218-273X/14/1/71

3. “Polyphenols: Role in Modulating Immune Function and Obesity”
by Md Abdullah Al Mamun, Ahmed Rakib, Mousumi Mandal, Santosh Kumar, Bhupesh Singla and Udai P. Singh
Biomolecules 2024, 14(2), 221; https://doi.org/10.3390/biom14020221
Full text available online: https://www.mdpi.com/2218-273X/14/2/221

4. “Blood Biomarkers of Alzheimer’s Disease and Cognition: A Literature Review”
by Greta Garcia-Escobar, Rosa Maria Manero, Aida Fernández-Lebrero, Angel Ois, Irene Navalpotro-Gómez, Victor Puente-Periz, José Contador-Muñana, Isabel Estragués-Gazquez, Albert Puig-Pijoan and Joan Jiménez-Balado
Biomolecules 2024, 14(1), 93; https://doi.org/10.3390/biom14010093
Full text available online: https://www.mdpi.com/2218-273X/14/1/93

5. “The Possible Roles of IL-4/IL-13 in the Development of Eosinophil-Predominant Severe Asthma”
by Kazuyuki Nakagome and Makoto Nagata
Biomolecules 2024, 14(5), 546; https://doi.org/10.3390/biom14050546
Full text available online: https://www.mdpi.com/2218-273X/14/5/546

6. “Real-World Safety and Effectiveness of Voretigene Neparvovec: Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study”
by M. Dominik Fischer, Francesca Simonelli, Jayashree Sahni, Frank G. Holz, Rainer Maier, Christina Fasser, Andrea Suhner, Daniel P. Stiehl, Bee Chen, Isabelle Audo et al.
Biomolecules 2024, 14(1), 122; https://doi.org/10.3390/biom14010122
Full text available online: https://www.mdpi.com/2218-273X/14/1/122

7. “Kidney Fibrosis and Oxidative Stress: From Molecular Pathways to New Pharmacological Opportunities”
by Francesco Patera, Leonardo Gatticchi, Barbara Cellini, Davide Chiasserini and Gianpaolo Reboldi
Biomolecules 2024, 14(1), 137; https://doi.org/10.3390/biom14010137
Full text available online: https://www.mdpi.com/2218-273X/14/1/137

8. “Hydrogen Sulfide (H₂S)/Polysulfides (H₂S_n) Signalling and TRPA1 Channels Modification on Sulfur Metabolism”
by Hideo Kimura
Biomolecules 2024, 14(1), 129; https://doi.org/10.3390/biom14010129
Full text available online: https://www.mdpi.com/2218-273X/14/1/129

9. “Reproductive and Oncologic Outcomes in Young Women with Stage IA and Grade 2 Endometrial Carcinoma Undergoing Fertility-Sparing Treatment: A Systematic Review”
by Andrea Etrusco, Antonio Simone Laganà, Vito Chiantera, Mislav Mikuš, Hafiz Muhammad Arsalan, Antonio d’Amati, Amerigo Vitagliano, Ettore Cicinelli, Alessandro Favilli and Antonio D’Amato
Biomolecules 2024, 14(3), 306; https://doi.org/10.3390/biom14030306
Full text available online: https://www.mdpi.com/2218-273X/14/3/306

10. “Brain-Derived Neurotrophic Factor, Nociception, and Pain”
by Adalberto Merighi
Biomolecules 2024, 14(5), 539; https://doi.org/10.3390/biom14050539
Full text available online: https://www.mdpi.com/2218-273X/14/5/539

MDPI will be attending the 9th Sino-American Workshop on Biomedical Engineering (SAWBE) and China–Oversea Joint Workshop on Biomechanics (COWB), held in Chengdu, China, from 22 to 26 July 2025, at booth# 14.

The 9th Sino-American Workshop on Biomedical Engineering and China–Oversea Joint Workshop on Biomechanics is one of the series of academic exchange activities held every three years. The purpose of the workshop is to further strengthen academic exchanges and cooperation among Chinese scholars at home and abroad, and to promote the development of biomedical engineering and biomechanics in our country. Since its inception in 2001 (first session, Beijing), the workshop has successfully held eight sessions: the second session in 2004 (Shanghai/Chengdu/Beijing), the third session in 2007 (Guangzhou), the fourth session in 2010 (Chongqing), the fifth session in 2013 (Beijing), the sixth session in 2016 (Shanghai), the seventh session in 2019 (Chongqing), and the eighth session in 2022 (Beijing). It has become a series of high-end conferences with brand recognition in the field, significantly promoting international cooperation and talent cultivation, and facilitating the development of biomedical engineering and biomechanics in our country.

The following MDPI journals will be represented:

• Biomechanics;
• Biology;
• Current Oncology;
• Medical Sciences;
• Journal of Developmental Biology;
• Biomolecules;
• Biophysica.

Our representatives, Ms. Callie Liu and Mr. Kent Zhang, are eager to answer your questions and address any inquiries you may have.

If you are attending this conference, please feel free to start a conversation with us at our booth. For more information about the conference, please visit the following website: https://www.sawbe2025.com/site/pages/index/index?pageId=ca390000-f8ac-3e07-a2bb-08dcfd75c495.

Six new journals covering a range of subjects launched their inaugural issues in June 2025. We are excited to be able to share with you the newest research rooted in the value of open access. We are pleased to present the latest research and to make it accessible to all.

We extend our sincere thanks to all the Editorial Board Members for their commitment and expertise. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, ensuring impactful open access scholarship.

Please feel free to browse and discover more about the new journals below.

Journal	Founding Editor-in-Chief	Journal Topics (Selected)
	Prof. Dr. Chang-Pu Sun, China Academy of Engineering Physics, Beijing, China; Computational Science Research Center, China Editorial | View inaugural issue	quantum information and phenomena; condensed matter physics and statistical physics; atomic, molecular, and optical physics; computational physics and mathematical methods View journal scope | Submit an article
	Prof. Dr. Hualiang Lin, Sun Yat-sen University, China; Prof. Dr. Jose L. Domingo, Universitat Rovira i Virgili, Spain Editorial | View inaugural issue	green and organic food; green infrastructures; green exercise; environmental impact of the healthcare sector; effects of climate change on human health | View journal scope | Submit an article
	Prof. Dr. Francesco Veglio, University of L’Aquila, Italy Editorial | View inaugural issue	ultra-pure substances; water purification; air purification; gas purification; inorganic chemical purification; purification technologies View journal scope | Submit an article
	Prof. Dr. Junxing Zheng, Huazhong University of Science and Technology, China Editorial | View inaugural issue	computer-aided design and engineering; artificial intelligence and machine learning; building information modeling (BIM) and digital twins; robotics and automation in construction; smart sensors and Internet of Things (IoT); intelligent control systems and facilities management View journal scope | Submit an article
	Prof. Dr. Assunta Di Vaio, University of Naples Parthenope, Italy Editorial | View inaugural issue	sustainability, managerial, and biodiversity accounting; carbon management accounting; corporate social responsibility; artificial intelligence and disclosure View journal scope | Submit an article
	Prof. Dr. Changjun Liu, Sichuan University, China Editorial | View inaugural issue	bioeffects of electromagnetic waves; electromagnetic science and engineering; microwave, millimeter-wave, and terahertz technologies; metamaterials and metasurfaces; communication, sensing, and networks; energy, power, and sustainable applications; quantum and emerging technologies; artificial intelligence and advanced fabrication View journal scope | Submit an article

Conference: The CRS 2025 Annual Meeting and Exposition
Date: 14–18 July 2025
Location: Philadelphia, USA

This conference will be the 52nd annual conference of the Controlled Release Society. The annual CRS conference is the most important conference in the pharmaceutics field. The main topics of the conference include nanomedicine and nanoscale delivery, immuno delivery, oral delivery, skin and mucosal delivery, ocular delivery, bioengineering, gene delivery and gene editing, alternative methods to animal testing, long-acting drug delivery formulations, delivery to the nervous system, artificial intelligence, and predictive models in pharmaceutical technologies.

The following open access journals will be represented at the event:

• Pharmaceutics;
• Gels;
• Pharmaceuticals;
• Biomedicines;
• Bioengineering;
• Biomolecules;
• Sci. Pharm;
• CIMB;
• Future Pharmacology.

If you plan to attend this conference, please contact us online. Our delegates look forward to meeting you in person at booth #202 and answering any questions you may have. For more information about the conference, please visit the following website: https://crs2025annualmeeting.eventscribe.net.

In order to further enhance the international influence of Biomolecules (ISSN: 2218-273X), promote academic exchange among young scientists, and support the Editorial Board with additional expertise, the journal would like to invite interested and eligible early career researchers to apply for Early Career Editorial Board (ECEB) membership.

We plan to recruit a total of 50 Early Career Editorial Board Members. The position can be held for two years, with the possibility of renewal for a second term.

Eligibility criteria of applicants:

• Candidates must have completed their doctorate/Ph.D. degree in the past 10 years (considering exceptions for career interruptions, including medical and family leave);
• There must be evidence that they have made significant research achievements in the field of structures and functions of bioactive and biogenic substances, molecular mechanisms with biological and medical implications and biomaterials and their applications;
• Candidates must be willing to dedicate their time to the development of the journal;
• They must be active and engaged in their community (e.g., experienced at presenting at academic conferences or involved in professional organizations).

Benefits of an Early Career Editorial Board Member:

• A certificate of appointment as an Early Career Editorial Board Member will be provided;
• The achievements of Early Career Editorial Board Members are publicized on the journal’s media platforms to improve their academic visibility;
• There will be an opportunity to be promoted to Editorial Board Member based on contributions;
• The journal will regularly acknowledge those who participated in the peer-review process on the journal’s website;
• Opportunities will be presented to participate in or host annual meetings and online seminars organized by the Editor-in-Chief and Editorial Board Members.

Responsibilities of an Early Career Editorial Board Member:

• Publicizing and promoting the journal at academic conferences and among peers;
• Selecting high-quality articles and preparing bilingual media content for promotion;
• Reviewing at least four manuscripts per year;
• Providing input on any new initiatives of journal development;
• Garnering submissions from local and overseas world-leading scientists in related research fields.

Applications:

Please send the application form and your academic resume to biomolecules@mdpi.com with the subject “Biomolecules Early Career Editorial Board Application + Name + Institute + Research Expertise”.

Application deadline: 20 September 2025.

Selection process and announcement:

The selection process: initial screening of application materials → selection by the Editor-in-Chief and Editorial Board Members → email notification → issuing a certificate of appointment.

The selection will be made within one month of the application deadline, and the results will be announced on the journal’s website.

We are pleased to share that Biomolecules (ISSN: 2218-273X) was awarded an updated Impact Factor of 4.8 in the 2024 Journal Citation Reports™ released by Clarivate™ in June 2025. Biomolecules ranks in Q1 (75/319) in the “Biochemistry and Molecular Biology” category.

The 2024 Journal Impact Factor is calculated by dividing the number of citations received in 2024 to all publications in the journal from 2022 and 2023 by the total number of citable publications from those same years.

To learn more, visit our journal statistics website for detailed metrics or check out our news article for general information.

The support and dedication of all the editors, reviewers, authors, and readers are an integral part of the journal’s performance. We would like to take this opportunity to thank all of you who have contributed to the journal.

Conference: The 9th EPNOE International Polysaccharide Conference
Date: 25–28 August 2025
Place: Sundsvall, Sweden

We are excited to announce that MDPI journals will participate as exhibitors in the 9th EPNOE International Polysaccharide Conference, which will be held from 25 to 28 August 2025.

This bi-annual conference aims to facilitate impactful discussions and networking among expert professionals from both academia and industry.

The EPNOE conference focuses on polysaccharides and their role in research and development. It is one of the largest gatherings in this field, promoting close academic–industry interactions, particularly in areas like cellulose and renewable resources.

The following MDPI journals will be presenting at the conference:

• Polymers;
• Polysaccharides;
• Macromol;
• Gels;
• Compounds;
• Biomolecules;
• Marine Drugs.

If you are planning to attend the conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.epnoe2025.org/.

We are pleased to share that Biomolecules (ISSN: 2218-273X) has received an updated CiteScore of 9.2 in June 2025. The CiteScore ranks the journal 64 out of 441 titles (Q1) in the “Biochemistry” category and 77 out of 410 titles (Q1) in the “Molecular Biology” category, an impressive achievement for a journal running in Volume 15.

You can find more statistics on https://www.mdpi.com/journal/biomolecules/stats.

The current CiteScores measure the average number of citations within a journal over a four-year window (2021–2024). The Scopus database provides a comprehensive suite of metrics that support informed publishing strategies, research evaluation and enable benchmarking of journal performance.

This achievement reflects the collective efforts of our authors, reviewers, and editors. Together we will continue to track the progress of Biomolecules and its growing impact in the intersection between chemistry, biology, molecular medicine and material sciences.